ARS Pharmaceuticals, Inc. (SPRY) has 10 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 2, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 2, 2026 filed Sept. 1, 2026 | Smith Margaret Ekins Chief Commercial Officer | $0 | 1,001,738 | 0% | No | |
|
|
||||||
| June 26, 2026 filed June 24, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | $0 | 30,000 | 0% | No | |
|
|
||||||
| June 26, 2026 filed June 24, 2026 | Dadoo Rajeev Director | $0 | 30,000 | 0% | No | |
|
|
||||||
| June 26, 2026 filed June 24, 2026 | SAUNDERS BRENT L Director | $0 | 30,000 | 0% | No | |
|
|
||||||
| June 26, 2026 filed June 24, 2026 | SCHNEIDER PHILLIP M Director | $0 | 30,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free